Balchem (BCPC) Cash & Equivalents (2010 - 2026)

Balchem (BCPC) has 17 years of Cash & Equivalents data on file, last reported at $72.9 million in Q1 2026.

• Quarterly Cash & Equivalents rose 46.04% year-over-year to $72.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72.9 million (up 46.04% YoY) and the FY2025 annual result came in at $74.6 million, up 50.6% from the prior year.
• Cash & Equivalents retreated to $72.9 million in Q1 2026 per BCPC's latest filing, from $74.6 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $77.0 million in Q3 2023 and bottomed at $49.5 million in Q4 2024.
• The 5-year median for Cash & Equivalents is $65.1 million (2025), against an average of $65.1 million.
• The widest annual swing landed in 2022, when Cash & Equivalents sank 37.24%; it then jumped 50.6% in 2025.
• Tracing BCPC's Cash & Equivalents over 5 years: stood at $66.6 million in 2022, then dropped by 3.17% to $64.4 million in 2023, then slipped by 23.17% to $49.5 million in 2024, then jumped by 50.6% to $74.6 million in 2025, then decreased by 2.28% to $72.9 million in 2026.
• Per Business Quant, the three latest BCPC Cash & Equivalents figures stand at $72.9 million (Q1 2026), $74.6 million (Q4 2025), and $65.1 million (Q3 2025).

Peer Comparison